Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis
Status:
Completed
Trial end date:
2021-01-31
Target enrollment:
Participant gender:
Summary
Brief summary: This study compares the long-term efficacy and safety of interferon (IFN) α2a
and cyclosporine (cyclosporin A, CsA) following suppression of acute attack by high-dose oral
glucocorticosteroid in patients with refractory Behçet's uveitis (BDU). Half of the
participants will receive IFNα2a while the other half will receive CsA.